Загрузка...
Pretreatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy
BACKGROUND: While it is well known that teriparatide (TPTD) increases bone mineral density (BMD) in osteoporotic patients, it is unknown whether TPTD pretreatment affects BMD after denosumab (DMAb) therapy. METHODS: Fifty-seven patients in TPTD-pretreated group and 35 patients in DMAb-alone group ha...
Сохранить в:
| Опубликовано в: : | Ther Clin Risk Manag |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5892610/ https://ncbi.nlm.nih.gov/pubmed/29662314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S154686 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|